Dr. Mohammad Muhsin Chisti

Get to Know Dr. Mohammad Muhsin Chisti

Dr. Mohammad Muhsin Chisti is a medical oncologist, researcher and educator at Corewell Health. He also serves as an associate professor at Oakland University William Beaumont School of Medicine, where he teaches medical students, residents and fellows.

Dr. Chisti serves as core faculty for Beaumont’s internal medicine residency and fellowship programs. Over more than 16 years in medical education, he has helped train the next generation of physicians. His academic work includes more than 80 peer-reviewed publications, posters and abstracts.

He has also served as principal investigator for nearly 27 national and international clinical trials. Before joining Corewell Health, Dr. Chisti was medical director at Barbara Ann Karmanos Cancer Institute.

Specialties of Dr. Mohammad Muhsin Chisti

• Breast cancer
• Gastrointestinal cancer
• Hematology
• Lung cancer
• Medical oncology
• Multiple myeloma
• Pleural mesothelioma
• Prostate cancer
• Urologic oncology

Dr. Chisti’s Experience and Medical Education

• Corewell Health, Hematologist-Oncologist
• Oakland University William Beaumont School of Medicine, Associate Professor
• Barbara Ann Karmanos Cancer Institute, Former Medical Director
• Corewell Health William Beaumont University Hospital (Hematology and Medical Oncology Fellowship)
• University at Buffalo State University of New York School of Medicine & Biomedical Sciences (Internal Medicine Residency) 
• Kashmir University Government Medical College (M.D.)

Awards and Certifications

• American Board of Internal Medicine, Board Certified in Hematology, 2014
• American Board of Internal Medicine, Board Certified in Medical Oncology, 2013
• American Board of Internal Medicine, Board Certified in Internal Medicine, 2010
• Hour Detroit Top Doc, selected for 6 consecutive years
• Best Outgoing Graduate, University at Buffalo
• Research Award, Roswell Park Comprehensive Cancer Center
• Clinical Research Award, American College of Physicians

Why Choose Dr. Chisti for Pleural Mesothelioma

Dr. Chisti’s experience in medical oncology and clinical research includes studying new approaches to cancer treatment. His work with clinical trials is particularly relevant for people with pleural mesothelioma who may want to explore options beyond standard treatments, including clinical trials.

Dr. Chisti’s approach reflects the importance he places on both the science of cancer treatment and the people receiving it. He aims to give patients and their families evidence-based care while keeping quality of life central to treatment decisions.

Publications of Dr. Mohammad Muhsin Chisti

• Chisti, M.M. et al. (2026, October 22). Adult-onset giant cell glioblastoma with biallelic PMS2 inactivation in Lynch syndrome. Retrieved from https://academic.oup.com/noa/article/8/1/vdag256/8985553
• Chisti, M.M. et al. (2025, July 22). SGLT2 inhibitors and cardiovascular outcomes in patients with multiple myeloma and concomitant type 2 diabetes mellitus. Retrieved from https://www.tandfonline.com/doi/full/10.1080/10428194.2025.2536681
• Chisti, M.M. et al. (2025, March 25). Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy. Retrieved from https://onlinelibrary.wiley.com/doi/10.1002/cam4.70831
• Chisti, M.M. et al. (2024, June 13). Non-Hodgkin lymphoma mortality disparities across different sexes, races, and geographic locations. Retrieved from https://journals.sagepub.com/doi/10.1177/10815589241262003
• Chisti, M.M. et al. (2023, December 28). Mortality trends of chronic lymphocytic leukaemia in the United States with the emergence of targeted therapy. Retrieved from https://onlinelibrary.wiley.com/doi/10.1111/bjh.19276